STANDIGM
Standigm is a workflow AI-driven drug discovery company. Standigm has proprietary AI platforms encompassing novel target identification to lead generation to generate commercially valuable drug pipelines. Founded in 2015, the company has established an early-stage drug discovery workflow AI to generate First-in-Class lead compounds within seven months. Pursuing full-stack, AI-driven industrializing drug discovery, Standigm has achieved the automation of molecular design workflow through DarkMolFactoryโข, and the automation effort has been expanding to the whole drug discovery process on the basis of Standigm AI platforms, including Standigm ASKโข for target discovery, Standigm BESTโข for lead design, and Standigm Insightโข for drug repurposing.
STANDIGM
Industry:
Artificial Intelligence Biotechnology Health Care Machine Learning Pharmaceutical
Founded:
2015-05-04
Address:
Seoul, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.standigm.com
Total Employee:
101+
Status:
Active
Contact:
82-2-501-8118
Email Addresses:
[email protected]
Total Funding:
71.24 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Google Universal Analytics Apache
Similar Organizations
Insilico Medicine
Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.
Menten AI
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
Visit
AI driven chatbot to provide health advice within minutes.
Current Employees Featured
Founder
Investors List
Pavilion Capital
Pavilion Capital investment in Series D - Standigm
SK Global Chemical
SK Global Chemical investment in Corporate Round - Standigm
Kakao Ventures
Kakao Ventures investment in Series C - Standigm
KDB Bank
KDB Bank investment in Series C - Standigm
Atinum Investment
Atinum Investment investment in Series C - Standigm
SKS PE
SKS PE investment in Series C - Standigm
WONIK Investment Partners
WONIK Investment Partners investment in Series C - Standigm
Asset One
Asset One investment in Series C - Standigm
DSC Investment
DSC Investment investment in Series C - Standigm
InterVest Co.
InterVest Co. investment in Series C - Standigm
Newest Events participated
Key Employee Changes
Date | New article |
---|---|
2022-08-18 | Standigm names Carl Foster chief business officer to expand strategic partnerships for AI drug discovery |
Official Site Inspections
http://www.standigm.com Semrush global rank: 2.42 M Semrush visits lastest month: 7.44 K
- Host name: 172.67.71.61
- IP address: 172.67.71.61
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago